Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label crossover PK study of intravaginal gonadorelin and oxybutynin in healthy women
NL-OMON42626Active, not recruiting
- Sponsor
- LiGalli
- Start
- Nov 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of gonadorelin and oxybutynin, sponsored by LiGalli. Primary endpoints: Pharmacokinetic parameters of oxybutynin and Pharmacokinetic parameters of gonadorelin. Started Nov 2015; status: active, not recruiting.
02
Drugs
gonadorelinoxybutynin
Beyond the preview
Go deeper on NL-OMON42626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42626.